The relationship of estrogen receptor-α polymorphism with symptoms and other characteristics in post-menopausal women

Maturitas

Volumn 49, Issue 2, 2004, Pages 163-169

  Malacara, Juan Manuel ^a   Pérez Luque, Elva Leticia ^a   Martínez Garza, Sandra ^a   Sánchez Marín, Francisco Javier ^b  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b CENTRO DE INVESTIGACIONES EN ÓPTICA   (Mexico)

Author keywords

Bone mineral density; Depression; Estrogen; Estrogen receptor polymorphism; Menopause

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; ANXIETY; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE; HOT FLUSH; HUMAN; HUMAN CELL; KARYOTYPE 46,XX; LUTEINIZING HORMONE BLOOD LEVEL; MEASUREMENT; MENOPAUSAL SYNDROME; POSTMENOPAUSE; RADIOGRAPHY; SCORING SYSTEM; SLEEP DISORDER; VAGINAL DRYNESS;

ANXIETY; BONE DENSITY; CROSS-SECTIONAL STUDIES; DEPRESSION; EDUCATIONAL STATUS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; GENETIC MARKERS; GENOTYPE; HOT FLASHES; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; QUESTIONNAIRES; REGRESSION ANALYSIS; SLEEP DISORDERS; VAGINA;

EID: 4944254029     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.01.002     Document Type: Article

References (24)

1. Weel A.E.A.M., Uitterlinden A.G., Westendorp I.C.D., Burger H., Schuit S.C.E., Hofman A., et al. Estrogen receptor polymorphism predicts the onset of natural an surgical menopause. J. Clin. Endocrinol. Metab. 84:1999;3146-3150
2. Lorentzon M., Lorentzon R., Bäckström T., Nordström P. Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross sectional and longitudinal study. J. Clin. Endocrinol. Metab. 84:1999;4597-4601
3. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res. 11:1996;306-311
4. Kunnas T.A., Laippala P., Penttilä A., Lehtimäki T., Karhunen P.J. Association of polymorphism of human oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ. 321:2000;273-274
5. Herrington D.M., Howard T.D., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., et al. Estrogen receptor polymorphism and effects on estrogen replacement therapy on high density lipoprotein cholesterol in women with coronary disease. N. Engl. J. Med. 346:2002;967-974
6. Kobayashi N., Fujino T., Shirgane T., Furuta I., Kobamatsu Y., Yaegashi M., et al. Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas. 41:2002;193-201
7. Han K., Choi J., Moon I., Yoon H., Han I., Min H., et al. Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri- and post-menopausal women. Osteoporos Int. 9:1999;290-295
8. Vandevyver C., Vanhoof J., Decleck K., Stinissen P., Vandervorst C., Michiels L., et al. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history and muscle strength in elder women. J. Bone Miner. Res. 14:1999;1576-1582
9. Ioannidis J.P., Stavrou I., Trikalinos T.A., Zois C., Brandi M.L., Gennari L., et al. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women. J. Bone Mineral. Res. 17:2002;2048-2060
10. Velasco E., Malacara J.M., Cervantes F., Díaz de León J., Dávalos G., Castillo J. Gonadotropins and prolactin serum levels during the perimenopausal period: correlation with diverse factors. Fertil. Steril. 53:1990;56-60
11. Sherwin BB. Impact of the changing hormonal milieu on psychological functioning. In: Lobo RA, editor. Treatment of the post-menopausal women. Basic and clinical aspects. New York: Raven Press; 1994.
12. Huerta M.R., Mena A., Malacara J.M., Díaz de León J. Symptoms at perimenopausal period: its association with attitudes toward sexuality, life-style, family function and FSH levels. Psychoneuroendocrinology. 20:1995;135-148
13. Malacara J.M., Canto de Cetina T., Bassol S., González N., Cacique L., Vera-Ramírez M.L., et al. Symptoms at pre- and post-menopause in rural and urban women from three states of Mexico. Maturitas. 43:2002;11-19
14. Bech P. The proper use of rating scales in depression. In: Smeets RMW, editor. Focus on depression, vol. 1. The Netherlands: Bagamor Pharma; 1990. p. 76-85.
15. Rocha M., Nava L.E., Vázquez de la Torre C., Sánchez- Marín F., Garay-Sevilla M.E., Malacara J.M. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial. J. Periodontol. 72:2001;204-209
16. Burger H.G., Dudley E.C., Hopper J.L., Shelley J.M., Green A., Smith A., et al. The endocrinology of menopausal transition: a cross-sectional study of a population-based study. J. Clin. Endocrinol. Metab. 80:1995;3537-3541
17. Burger H.G., Dudley E.C., Hopper J.L., Groome N., Gathrie J.R., Green A., et al. Prospectively measured levels of follicle-stimulating hormone % estradiol and dimeric inhibin during the menopausal transition in a population-based cohort. J. Clin. Endocrinol. Metab. 84:1999;4025-4030
18. Malacara J.M., Fajardo M.E., Nava L.E. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids. 66:2001;559-567
19. Arborelius I., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin releasing factor in depression and anxiety disorders. J. Endocrinol. 160:1999;1-12
20. Belcher S.M., Zsarnovszky A. Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J. Pharmacol. Exp. Ther. 299(2):2001;408-414
21. Sarlio-Lähtenkorva S., Lahelma E. The association of body mass index with social and economic disadvantage in women and men. Int. J. Epidemiol. 29:1999;445-449
22. Ushiroyama T., Heishi M., Ikeda A., Ueki M. Does estrogen receptor gene polymorphism relate to undefined menopausal symptoms? Res. Commun. Mol. Pathol. Pharmacol. 109:2001;3-14
23. Longcope C. Metabolic clearance rate and blood production rates of estrogens in post-menopausal women. Am. J. Obstet. Gynecol. 111:1971;778-781
24. Siiteri P, MacDonald P. Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB, editors. Handbook of physiology (female reproductive system). Section 7: Endocrinology, vol. II. Washington, DC: American Physiological Society; 1973. p. 615-30.